Promega Corporation

ApoLive-Glo™ Multiplex Assay

Predictive Mechanism of Toxicity Determination

  • Measure viability and apoptosis in the same sample well: Accurately determine mechanism of cell death in the same sample well, save time and use less cells.
  • Easily implement: The assay follows a simple sequential "add-mix-measure" protocol.
  • Normalize caspase data with a viability control: The ratio of caspase activity to viable cells is useful for determining the extent of caspase activation and for normalizing cell numbers.
  • Flexible and easily automated: Component volumes can be scaled to meet throughput needs, and reagents are robust for automation in 96- to 1536-well plate formats.

Predictive Mechanism of Toxicity Determination

6601MC

Predictive measures of viability and apoptosis in the same well

8141MC-300

Primary Necrosis

  • Ionomycin treatment of Jurkat cells for 6 hours
  • Dose-dependent decrease in viability
  • No caspase-3/7 activation
8140MB-300

Apoptosis

  • Staurosporine treatment of Jurkat cells for 6 hours
  • Dose-dependent decrease in viability
  • Increase in caspase-3/7 activation

Simple add-mix-measure protocol and scalable assay reagents make the assay easy to implement and adaptable for 96- to 1536-well formats.

8175MB
6865MB

24-hour paclitaxel treatment of Jurkat cells results in dose-dependent decrease in cell viability and increase in caspase-3/7 activity.

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »